SB477
Senate · 2026 sessionRepublicanInterim study340B drug program transparency
AI-generatedEstablishes reporting requirements for the department of health and human services, hospitals, and other entities participating in the 340B Drug Pricing Program and directs the department to require claim-level identifiers and exclusion rules to prevent duplicate discounts.
relative to increasing transparency in the 340B Drug Pricing Program.Official record
Public and Mental HealthState GovernmentWelfare/Medicare/MedicaidAI-generated
Division of testimonyComputed by this site
0 submissionsSupport 0Oppose 0Neutral 0
Status
Referred to interim study (Senate) · March 5, 2026- ✓Introduced
- Senate
- House
- Governor
- Law
The record · every submission as filed
0 submissionsNo testimony matches these filters. Clear the search or set position to All.